What is HC Wainwright’s Estimate for Calumet Q2 Earnings?

Calumet, Inc. (NASDAQ:CLMT) – Investment analysts at HC Wainwright reduced their Q2 2026 earnings estimates for Calumet in a research report issued to clients and investors on Monday, May 11th. HC Wainwright analyst A. Dayal now forecasts that the oil and gas company will earn ($0.62) per share for the quarter, down from their previous forecast of ($0.59). HC Wainwright has a “Buy” rating and a $60.00 price target on the stock. The consensus estimate for Calumet’s current full-year earnings is ($0.18) per share. HC Wainwright also issued estimates for Calumet’s Q3 2026 earnings at ($0.29) EPS, Q4 2026 earnings at ($0.33) EPS, FY2026 earnings at ($1.89) EPS and FY2027 earnings at $0.69 EPS.

Calumet (NASDAQ:CLMT) last released its quarterly earnings data on Friday, May 8th. The oil and gas company reported ($3.64) earnings per share for the quarter, missing the consensus estimate of ($0.33) by ($3.31). The business had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $1 billion. During the same quarter last year, the firm posted ($1.87) EPS. The company’s revenue was up 3.6% on a year-over-year basis.

Several other research analysts also recently weighed in on CLMT. UBS Group restated a “neutral” rating and set a $26.00 price objective on shares of Calumet in a report on Friday, February 13th. TD Cowen upped their price objective on shares of Calumet from $19.00 to $25.00 and gave the stock a “hold” rating in a report on Thursday, March 5th. The Goldman Sachs Group downgraded shares of Calumet from a “buy” rating to a “neutral” rating and set a $36.00 price objective on the stock. in a report on Friday, April 24th. Finally, Weiss Ratings upgraded shares of Calumet from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $33.60.

Calumet Trading Down 0.6%

CLMT opened at $32.12 on Wednesday. The company’s fifty day moving average price is $31.62 and its two-hundred day moving average price is $24.99. Calumet has a 1-year low of $12.70 and a 1-year high of $36.94. The company has a market cap of $2.79 billion, a price-to-earnings ratio of -14.87 and a beta of 0.72.

Insider Transactions at Calumet

In related news, Director Daniel J. Sajkowski sold 3,310 shares of the firm’s stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $34.46, for a total transaction of $114,062.60. Following the completion of the sale, the director owned 81,958 shares in the company, valued at approximately $2,824,272.68. This trade represents a 3.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 4.07% of the company’s stock.

Institutional Trading of Calumet

A number of large investors have recently added to or reduced their stakes in CLMT. Legal & General Group Plc increased its holdings in Calumet by 36.6% during the second quarter. Legal & General Group Plc now owns 72,143 shares of the oil and gas company’s stock worth $1,137,000 after buying an additional 19,322 shares during the last quarter. New York State Common Retirement Fund purchased a new stake in Calumet during the second quarter worth about $343,000. Quantbot Technologies LP purchased a new stake in Calumet during the second quarter worth about $241,000. Invesco Ltd. increased its holdings in Calumet by 514.8% during the second quarter. Invesco Ltd. now owns 94,642 shares of the oil and gas company’s stock worth $1,491,000 after buying an additional 79,247 shares during the last quarter. Finally, The Manufacturers Life Insurance Company increased its holdings in Calumet by 199.9% during the second quarter. The Manufacturers Life Insurance Company now owns 34,551 shares of the oil and gas company’s stock worth $544,000 after buying an additional 23,031 shares during the last quarter. Hedge funds and other institutional investors own 34.41% of the company’s stock.

Calumet Company Profile

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.